首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Biochimica et biophysica acta-reviews on cancer

缩写:BBA-REV CANCER

ISSN:0304-419X

e-ISSN:1879-2561

IF/分区:8.3/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1069
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Atieh Yaghoubi,Majid Khazaei,Saba Jalili et al. Atieh Yaghoubi et al.
Bacteria have long been known as one of the primary causative agents of cancer, however, recent studies suggest that they can be used as a promising agent in cancer therapy. Because of the limitations that conventional treatment faces due t...
Clara S Mundry,Kirsten C Eberle,Pankaj K Singh et al. Clara S Mundry et al.
Late detection, compromised immune system, and chemotherapy resistance underlie the poor patient prognosis for pancreatic ductal adenocarcinoma (PDAC) patients, making it the 3rd leading cause of cancer-related deaths in the United States. ...
Ling Qian,Yehua Shen,Jing Xie et al. Ling Qian et al.
As a promising area of tumor treatment, immunotherapies, such as immune checkpoint inhibitors, have been applied to various types of cancer. However, many patients do not respond to such therapies. Increasing application of tumor ablation t...
Tom van den Ende,Héctor G van den Boorn,Nadine M Hoonhout et al. Tom van den Ende et al.
Background: Chemotherapy (CT), radiotherapy (RT), and chemoradiotherapy (CRT) are able to alter the composition of the tumor immune microenvironment (TIME). Understanding the effect of these modalities on the TIME could a...
Sakthivel Muniyan,Lei Xi,Kaustubh Datta et al. Sakthivel Muniyan et al.
Androgen deprivation therapy (ADT) is the primary systemic therapy for treating locally advanced or metastatic prostate cancer (PCa). Despite its positive effect on PCa patient survival, ADT causes various adverse effects, including increas...
Tian-Jiao Li,Wen-Quan Wang,Xian-Jun Yu et al. Tian-Jiao Li et al.
Cancer regression often fails after systemic immune activation, especially for solid tumors due to their local immunosuppressive microenvironments. Among these, the pancreatic cancer microenvironment is unique and an important reason for re...
Zhang Cheng,Jiang Wei-Qi,Ding Jin Zhang Cheng
Liver cancer is highly malignant and insensitive to cytotoxic chemotherapy and is associated with very poor patient prognosis. In 2007, the small-molecule targeted drug sorafenib was approved for the treatment of advanced liver cancer. In t...
Elham Hatami,Meena Jaggi,Subhash C Chauhan et al. Elham Hatami et al.
The United States Food and Drug Administration has permitted number of therapeutic agents for cancer treatment. Most of them are expensive and have some degree of systemic toxicity which makes overbearing in clinical settings. Although adva...
Adrián Varela-Vázquez,Amanda Guitián-Caamaño,Paula Carpintero-Fernandez et al. Adrián Varela-Vázquez et al.
Cellular communication through gap junctions and hemichannels formed by connexins and through channels made by pannexins allows for metabolic cooperation and control of cellular activity and signalling. These channel proteins have been desc...
Lavanya Ponnusamy,Sathan Raj Natarajan,Karthik Thangaraj et al. Lavanya Ponnusamy et al.
Breast cancer is the most ubiquitous type of neoplasms among women worldwide. Molecular aberrations associated with breast development and progressions have been extensively investigated in recent years. An AMP-activated kinase (AMPK) initi...